Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma. Bhattacharyya S, Oblinger JL, Beauchamp RL, Yin Z, et al. Neuro Oncol 2023 Feb 20:noad037. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Bhattacharyya S, Oblinger JL, Beauchamp RL, Yin Z, et al. Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma. Neuro Oncol 2023 Feb 20:noad037. doi: 10.1093.
PMID: 36806881